Real-Time PCR Method Developed for Pharmacokinetic and Biodistribution Studies of Recombinant Adenovirus

Strategic Insights -

Scientists in Beijing, People's Republic of China, have developed a real-time PCR method for pharmacokinetic and biodistribution studies of recombinant adenovirus, specifically the Ad5-LFA-3/IgG(1) gene therapy treatment for psoriasis. The method showed good specificity, sensitivity, and reproducibility over a wide dynamic range of concentrations, providing valuable information for clinical trials.

Key Takeaways:

  • The researchers constructed a replication-deficient recombinant adenovirus (Ad5-LFA-3/IgG(1)) that encodes secreted LFA-3/IgG(1) for gene therapy treatment of psoriasis.
  • The real-time PCR method was developed to study the pharmacokinetics and biodistribution of Ad5-LFA-3/IgG(1) in the circulation and organs.
  • The method showed good specificity, sensitivity, and reproducibility, enabling quantitative measurement of recombinant adenoviral DNA in circulating blood and organs.
  • The level of Ad5-LFA-3/IgG(1) DNA in circulating blood peaked within 10 minutes following intravenous injection in rhesus macaques.
  • The adenoviral DNA level dropped significantly to a very low level after the peak.
  • Real-time PCR revealed that Ad5-LFA-3/IgG(1) DNA was enriched in the spleen, lung, and liver after injection of the adenovirus into rats through the tail vein.
  • Adenoviral DNA was barely detected in other tissues.
  • The developed real-time PCR assay provides important information for clinical trials of Ad5-LFA-3/IgG(1) and confirms the utility of the method for monitoring gene therapy trials.

Statistics:

  • 10 minutes: The timepoint at which the level of Ad5-LFA-3/IgG(1) DNA in circulating blood peaked following intravenous injection in rhesus macaques.
  • 43(2):130-7: The volume and page numbers of the journal article published in Molecular Biotechnology.

Sources:

  • Xu, X.X., et al. (2009). Development and application of a real-time PCR method for pharmacokinetic and biodistribution studies of recombinant adenovirus. Molecular Biotechnology, 43(2), 130-7.
  • Gene Therapy Weekly via NewsRx.com. (2009). Real-time PCR method developed for pharmacokinetic and biodistribution studies of recombinant adenovirus.
  • Beijing Institute of Microbiology and Epidemiology.